Expanding the Clinico-Genetic Spectrum of Myofibrillar Myopathy: Experience From a Chinese Neuromuscular Center
- 1Department of Neurology, Xiangya Hospital, Central South Hospital, Changsha, China
- 2Department of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
A Corrigendum on
Expanding the Clinico-Genetic Spectrum of Myofibrillar Myopathy: Experience From a Chinese Neuromuscular Center
by Luo, Y.-B., Peng, Y., Lu, Y., Li, Q., Duan, H., Bi, F., et al. (2020). Front. Neurol. 11:1014. doi: 10.3389/fneur.2020.01014
In the original article, there was a mistake in Table 1 as published. For patients 16 and 17, the protein alteration resulting from the c. 107545delG mutation should be p.Ala35849Glnfs*16. The corrected Table 1 appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: myofibrillar myopathy, desminopathy, titinopathy, BAG3opathy, filaminopathy, FHL1opathy
Citation: Luo Y-B, Peng Y, Lu Y, Li Q, Duan H, Bi F and Yang H (2021) Corrigendum: Expanding the Clinico-Genetic Spectrum of Myofibrillar Myopathy: Experience From a Chinese Neuromuscular Center. Front. Neurol. 11:636981. doi: 10.3389/fneur.2020.636981
Received: 02 December 2020; Accepted: 03 December 2020;
Published: 08 January 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Luo, Peng, Lu, Li, Duan, Bi and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Huan Yang, eWFuZ2g2OSYjeDAwMDQwOzEyNi5jb20=